Nature's Sunshine Products, Inc.

NASDAQ•NATR

CEO: Mr. Terrence O. Moorehead

セクター: Consumer Defensive

業種: Packaged Foods

上場日: 2009-06-25

Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.

連絡先情報

2901 West Bluegrass Boulevard, Suite 100, Lehi, UT, 84043, United States

801-341-7900

www.naturessunshine.com

時価総額

$419.72M

PER (TTM)

21.5

10.2

配当利回り

52週高値

$28.14

52週安値

$11.01

52週レンジ

76%

順位26Top 13.0%

5.5

F-Score

改良版 Piotroski 分析

10年ファンダメンタル

堅調 • 5.5 / 9 ポイント

スコアレンジ (0-9)

8-9: 価値が優れている

6-7: 基礎体質が強い

4-5: 全体的に堅調

0-3: パフォーマンスが弱い

データ期間: 2016-2025

財務ダッシュボード

Q4 2025 データ

売上高

$123.81M+0.00%

直近4四半期の推移

EPS

$0.23+0.00%

直近4四半期の推移

フリーCF

-$21.28M+0.00%

直近4四半期の推移

2025 Annual 決算ハイライト

主なハイライト

Consolidated Net Sales Increase Net sales grew 5.7% to $480.1M in 2025; local currency growth reached 5.3% excluding FX impact.

Net Income Attributable Growth Net income for common shareholders reached $19.5M, significantly up from $7.7M in 2024 due to operational leverage.

Cost of Sales Percentage Decline Cost of sales as percentage of net sales improved to 27.6% in 2025 from 28.5% in 2024 due to savings initiatives.

Operating Cash Flow Rises Cash provided by operating activities increased to $35.3M in 2025, up from $25.3M in 2024, driven by improved net income.

リスク要因

Trade Control Compliance Risk Internal investigation regarding U.S. trade controls resulted in voluntary self-disclosures to BIS and OFAC in 2025.

Foreign Exchange Rate Volatility 72.2% of 2025 net sales were international; strengthening USD negatively impacts reported sales and earnings translation.

Operating Expense Ratio Increase SG&A expenses rose to 37.2% of net sales in 2025 from 36.1% in 2024 due to compensation and marketing investments.

Direct Selling Regulatory Scrutiny Global laws restrict direct selling practices; non-compliance risk exists regarding product claims and consultant classification.

見通し

China Joint Venture Integration Completed acquisition of remaining China JV interests in 2025; now facing integration and broader China regulatory risks.

Share Repurchase Program Status $16.3M used for stock repurchase in 2025; $17.4M remains authorized for future purchases under current plan.

Monitoring Future Tariff Impacts No material tariff impact in 2025, but expects continued adverse cost pressure from tariffs into fiscal year 2026.

Internal Control Effectiveness Management concluded internal control over financial reporting was effective as of December 31, 2025, per auditor report.

同業比較

売上高 (TTM)

BGS

$1.83B

-5.4%

USNA

$925.26M

+8.3%

NATR

$480.14M

+5.7%

粗利益率 (最新四半期)

EWCZ

95.9%

-9.0pp

USNA

88.8%

-5.2pp

NATR

61.3%

+1.9pp

主要指標

銘柄コード	時価総額	PER (TTM)	ROE (TTM)	負債比率
NATR	$419.72M	21.5	12.2%	7.2%
BGS	$403.88M	-9.3	-8.9%	70.6%
WILC	$361.21M	12.1	18.5%	0.7%

長期トレンド

直近4四半期

売上高

純利益

営業キャッシュフロー

4四半期売上高CAGR

3.0%

緩やかな成長

4四半期純利益CAGR

-4.7%

収益性の安定

キャッシュフロー安定性

75%

キャッシュフローの変動が大きい

深度リサーチ

次回決算:2026年5月4日

EPS:-

売上高:-

財務データ

決算説明会

財務レポート

ニュース

損益計算書

バランスシート

キャッシュフロー計算書

財務比率

変化率

損益計算書	直近12ヶ月

データなし